GNLX.NASDAQGenelux CORP

Form 4: Genelux Corp Director Aladar Szalay Sells Shares in Multiple Transactions

Sentiment:

SEC Form 4 Filing


Director Aladar Szalay of Genelux Corp reports selling shares in multiple transactions on May 7th and 8th, 2024.

Summary

  • Aladar Szalay, a director of Genelux Corp, reported the sale of company shares on May 7th and May 8th, 2024.
  • On May 7th, 6,025 shares of common stock were sold at a weighted-average price of $3.6699.
  • On May 8th, 13,919 shares of common stock were sold at a weighted-average price of $3.8213.
  • The shares were sold in multiple transactions at prices ranging from $3.595 to $3.76 on May 7th and from $3.75 to $3.96 on May 8th.
  • Following these transactions, Aladar Szalay indirectly owns 1,175,787 shares through a trust, 5,000 shares through a spouse, 2,258,760 shares through The Szalay 2009 Irrevocable Trust and 550,000 shares through The Szalay 2010 Children's Trust.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting the sale of shares by a company director. It doesn't inherently convey positive or negative sentiment, but the market may interpret insider selling as slightly negative.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

  • Shareholders may react to the news of insider selling, potentially impacting the stock price.

Key Dates

DateDescription
05/07/2024Sale of 6,025 shares of Genelux Corp common stock.
05/08/2024Sale of 13,919 shares of Genelux Corp common stock.
05/09/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.